Skip to main content
. 2021 Jan 19;35(7):1999–2006. doi: 10.1053/j.jvca.2021.01.027

Table 3.

ECMO-Related Data in Patients With Severe COVID-19

Variables Overall Series (N = 132) 6-Month Survivors (N = 62) 6-Month Deaths (N = 70) p Value
Time from ICU admission to ECMO, days 5.8 (5.3) 5.3 (5.5) 6.2 (5.2) 0.182
Primary ECMO inflow vessel 0.395
 Femoral vein 90 (68.2) 40 (64.5) 50 (71.4)
 Jugular vein 42 (31.8) 22 (35.5) 20 (28.6)
Primary ECMO outflow vessel 0.286
 Femoral vein 21 (15.9) 11 (17.7) 10 (14.3)
 Jugular vein 102 (77.3) 49 (79.0) 53 (75.7)
 Femoral artery 9 (6.8) 2 (3.2) 7 (10.0)
Primary ECMO double-lumen cannula 23 (17.4) 11 (17.7) 12 (17.1) 1.000
Primary ECMO configuration 0.102
 VV ECMO 122 (92.4) 60 (96.8) 62 (88.6)
 VA ECMO 10 (7.6) 2 (3.2) 8 (11.4)
Second run ECMO configuration 0.513
 VV ECMO 6 (4.5) 4 (6.5) 2 (2.9)
 VA ECMO 3 (2.3) 1 (1.6) 2 (2.9)
 VAV ECMO 4 (3.0) 1 (1.6) 3 (4.3)
 VVA ECMO 1 (0.8) 0 1 (1.4)
Third run ECMO configuration 0.407
 VV ECMO 1 (0.8) 0 1 (1.4)
 VAV ECMO 1 (0.8) 0 1 (1.4)
Mean duration of ECMO, days 14.6 (11.0) 15.1 (9.8) 14.1 (12.0) 0.295

NOTE. Continuous values are reported as mean and standard deviation (in parentheses) and categorical variables as counts and percentages (in parentheses).

Abbreviations: COVID-19, coronavirus disease 2019; ECMO, extracorporeal membrane oxygenation; ICU, intensive care unit; VA, venoarterial; VAV, venoarterio-venous; VV, venovenous; VVA, veno-venoarterial.